search
Back to results

Effect of Fentanyl on Pain Severity and Duration of Labor

Primary Purpose

Decrease Labor Pain

Status
Terminated
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Fentanyl
Sponsored by
Mashhad University of Medical Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Decrease Labor Pain focused on measuring Fentanyl, analgesia, duration of the active phase, pain severity

Eligibility Criteria

21 Years - 37 Years (Adult)Female

Inclusion Criteria:

  • multiparas pregnant women (gravid 2-7),
  • term singleton pregnancy,
  • cephalic presentation,
  • low risk pregnancy with no history of drug tolerance (addiction),
  • medical and mental diseases.

Exclusion Criteria:

  • Respiratory rate ≤ 8 or maternal bradycardia (pulse rate less than 60).

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    Fentanyl

    Without Fentanyl

    Arm Description

    In case group, 50 micrograms fentanyl was prescribed in two doses with an interval of 1 hour. In control group was not intervention.

    The control group did not receive Fentanyl.

    Outcomes

    Primary Outcome Measures

    decrease pain and duration of the active phase considerably.

    Secondary Outcome Measures

    Full Information

    First Posted
    July 17, 2012
    Last Updated
    July 23, 2012
    Sponsor
    Mashhad University of Medical Sciences
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01648595
    Brief Title
    Effect of Fentanyl on Pain Severity and Duration of Labor
    Official Title
    Principal Investigator
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2006
    Overall Recruitment Status
    Terminated
    Study Start Date
    January 2006 (undefined)
    Primary Completion Date
    August 2006 (undefined)
    Study Completion Date
    September 2006 (undefined)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Mashhad University of Medical Sciences

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Background: There are two methods of pharmacologic and non- pharmacologic for reducing pain of delivery. It is necessary to be known effect of these drugs on the mother and fetus during labor adverse. Therefore, the purpose of this study was determination of effect of Fentanyl intravenously on pain severity during the active phase of labor.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Decrease Labor Pain
    Keywords
    Fentanyl, analgesia, duration of the active phase, pain severity

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Phase 2, Phase 3
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    70 (false)

    8. Arms, Groups, and Interventions

    Arm Title
    Fentanyl
    Arm Type
    Experimental
    Arm Description
    In case group, 50 micrograms fentanyl was prescribed in two doses with an interval of 1 hour. In control group was not intervention.
    Arm Title
    Without Fentanyl
    Arm Type
    No Intervention
    Arm Description
    The control group did not receive Fentanyl.
    Intervention Type
    Drug
    Intervention Name(s)
    Fentanyl
    Intervention Description
    In case group, 50 micrograms fentanyl was prescribed in two doses with an interval of 1 hour after being diluted in 4 cc normal saline
    Primary Outcome Measure Information:
    Title
    decrease pain and duration of the active phase considerably.
    Time Frame
    up to 8 months

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    21 Years
    Maximum Age & Unit of Time
    37 Years
    Eligibility Criteria
    Inclusion Criteria: multiparas pregnant women (gravid 2-7), term singleton pregnancy, cephalic presentation, low risk pregnancy with no history of drug tolerance (addiction), medical and mental diseases. Exclusion Criteria: Respiratory rate ≤ 8 or maternal bradycardia (pulse rate less than 60).

    12. IPD Sharing Statement

    Learn more about this trial

    Effect of Fentanyl on Pain Severity and Duration of Labor

    We'll reach out to this number within 24 hrs